1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with copper sulfate in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (copper sulfate) | Trials (copper sulfate) | Recent Studies (post-2010) (copper sulfate) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 2,179 | 64 | 605 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambrosio, G; Chiariello, M; Condorelli, M; Napoli, C; Palumbo, G; Triggiani, M | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and copper sulfate
Article | Year |
---|---|
Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Analysis of Variance; Copper Sulfate; Electrophoresis, Polyacrylamide Gel; Free Radical Scavengers; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Phospholipases A; Platelet Activating Factor; Reference Values; Regression Analysis; Superoxides; Xanthine; Xanthine Oxidase; Xanthines | 1997 |